Camp4 Therapeutics Corporation (CAMP)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | — | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-14) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-13) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-27) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-21) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Document and Entity Information | — |
|
| Audit Information | — |
|
| Statements | ||
| Unaudited Condensed Consolidated Balance Sheets | — |
|
| Consolidated Balance Sheets | ||
| Unaudited Condensed Consolidated Balance Sheets (P) | — |
|
| Consolidated Balance Sheets (P) | ||
| Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Unaudited Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders Equity (deficit) | — |
|
| Unaudited Condensed Consolidated Statements of Stockholders Equity | — |
|
| Consolidated Statements of Convertible Preferred Stock and Stockholders Equity (deficit) | — |
|
| Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit | ||
| Unaudited Condensed Consolidated Statements of Cash Flows | — |
|
| Consolidated Statements of Convertible Preferred Stock and Stockholders Equity (deficit) (P) | — |
|
| Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Cash Flows (P) | — |
|
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Basis of Presentation and Accounting Policies | — |
|
| Collaboration and License Agreements | ||
| Commitments and Contingencies | ||
| Convertible Preferred Stock and Stockholders' Deficit | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Derivative Tranche Liability | ||
| Description of Business and Basis of Presentation | ||
| Employee Benefit Plan | ||
| Fair Value Measurements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Net Loss Per Share Attributable To Common Stockholders | ||
| Other Balance Sheet Components | — |
|
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Property and Equipment, Net | ||
| Related Parties | ||
| Segment Reporting | ||
| Stock-based Compensation | ||
| Stockholders Equity | ||
| Subsequent Events | — |
|
| Summary of Significant Accounting Policies | ||